Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

CompletedOBSERVATIONAL
Enrollment

259

Participants

Timeline

Start Date

February 20, 2012

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Acute Graft-versus-Host DiseaseAllogeneic Stem Cell Transplant
Interventions
PROCEDURE

Blood samples

2-3 tablespoons of blood weekly for the first 100 days (about 14 weeks) following allogeneic transplant. In addition a blood sample will be obtained before starting the chemotherapy or radiation regimen for the transplant, in the day of the transplant and if your doctor suspects that you have acute graft-versus-host disease.

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT01521039 - Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease | Biotech Hunter | Biotech Hunter